Search results
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 1 month agoTakeda Pharmaceutical Co. Ltd. (NYSE:TAK) is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins...
Takeda tackles $900m restructuring plan after generics hurt annual profits
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoTakeda’s annual profits for FY 2023 have been hit by more than 50%, prompting the company to say it...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript October 27, 2023...
Japan's Takeda flags profit slide as it bolsters drug pipeline
Reuters via Yahoo News· 1 year agoTOKYO (Reuters) -Japan's Takeda Pharmaceutical Co on Thursday reported annual profit that missed...
Takeda's FY22 Net Profit Jumps 38%, But Expects Lower FY23 Revenues
Benzinga via Yahoo Finance· 1 year agoTakeda Pharmaceutical Co Ltd's (NYSE: TAK) FY22 net profit rose 37.8% to ¥317.02 billion, mainly due...
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
The Wall Street Journal· 2 weeks agoHEALTH Takeda Pharmaceutical reported a fourth-quarter loss and forecast a drop in annual net profit...
One Ultra-Cheap High-Yield Dividend Stock to Buy
Motley Fool via Yahoo Finance· 5 months agoDividend stocks that trade at cheap valuations can give investors multiple ways to profit from them. In addition to dividend income, you're also...
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
Benzinga via Yahoo Finance· 2 years agoTakeda Pharmaceutical Co Ltd's (NYSE: TAK) first-half net profit declined 9.2% from the prior year to ¥166.8 billion. Earnings per share fell 8.1% to...
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
Motley Fool· 9 months agoIf you're looking for a high-yield dividend stock in the healthcare sector, you might be interested...
Japan's Takeda to buy Nimbus' psoriasis drug for as much as $6 billion
Reuters via Yahoo News· 1 year agoThe drug, codenamed "NDI-034858", last week showed statistically significant reduction in...